Kidney cancer: CheckMate for advanced-stage ccRCC? Nivolumab and cabozantinib aMETEORate poor survival (Q86476732)
Jump to navigation
Jump to search
scientific article published on 13 October 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Kidney cancer: CheckMate for advanced-stage ccRCC? Nivolumab and cabozantinib aMETEORate poor survival |
scientific article published on 13 October 2015 |
Statements
Kidney cancer: CheckMate for advanced-stage ccRCC? Nivolumab and cabozantinib aMETEORate poor survival (English)
13 October 2015